| Income Statement | 2024-09-30 | 2024-06-30 | 2022-03-31 | 2021-09-30 |
|---|---|---|---|---|
| Revenues | 192 | 287 | 1,103 | 1,359 |
| Cost of goods sold | 35 | 58 | 353 | 512 |
| Gross profit | 157 | 229 | 750 | 847 |
| Research and development expenses | NaN | NaN | 264 | 601 |
| Selling, general and administrative expenses | 660 | 944 | 3,364 | 4,584 |
| Change in fair value of contingent stock consideration | NaN | NaN | -847 | 608 |
| Impairment of goodwill | NaN | NaN | 2,728 | NaN |
| Change in fair value of convertible promissory notes | NaN | NaN | NaN | 772 |
| Operating expenses | 660 | 944 | 5,509 | 5,793 |
| Gain from extinguishment of debt | NaN | NaN | NaN | 7 |
| Operating income (loss) | -503 | -715 | -4,759 | -4,946 |
| Interest income | NaN | 1 | 2 | 2 |
| Settlement income | NaN | NaN | 82 | NaN |
| Interest expense, other | 19 | 6 | 196 | 178 |
| Change in fair value of convertible promissory notes | -19 | -174 | -280 | NaN |
| Other nonoperating income (expense) | -38 | -179 | -392 | 603 |
| Income (loss) from continuing operations before income taxes, noncontrolling interest | -541 | -894 | -5,151 | -4,343 |
| [income tax expense (benefit)] | NaN | 3 | NaN | NaN |
| Net loss | -541 | -897 | -5,151 | -4,343 |
| Basic EPS | NaN | NaN | -0.07 | -0.07 |
| Diluted EPS | NaN | NaN | -0.07 | -0.07 |
| Basic Average Shares | NaN | NaN | 68,849,400 | 62,174,822 |
| Diluted Average Shares | NaN | NaN | 68,849,400 | 62,174,822 |
Avenir Wellness Solutions, Inc. (AVRW)
Avenir Wellness Solutions, Inc. (AVRW)